Anagrelide Capsules USP recall: Failed Dissolution
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC…
Why was Anagrelide Capsules USP recalled?
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # GD01090, Exp 05/2022
- Product
- Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC…
- Recalling firm
- Teva Pharmaceuticals USA Inc
- Quantity
- 4224 cartons
- Distribution
- Distributed Nationwide in the USA
- Recall date
- June 8, 2022
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)